(AFX UK Focus) 2009-11-26 09:08 UCB in talks with banks to refinance loan facility (Interactive Investor)
BRUSSELS, November twenty-six (Reuters) - Belgian curative organisation UCB has started discussions with banks to refinance loans it resolved 3 years ago to buy German counterpart Schwarz Pharma. UCB, the executive shaken complement as well as immunology specialist, paid for Schwarz for 4.4 billion euros ($6.64 billion) in 2006 as well as resolved the syndicated loan agreement.